Sionna Therapeutics develops experimental medicines for cystic fibrosis, a genetic disease that affects the lungs and other organs. It last closed at $3.07 on Nov 17, down 1.60% on the day.
Only 1 firm rated SION in the past 90 days, not enough for a consensus
Average 12-month target
$6.00
▲ 95.4% upside
Based on 1 analyst who set a price target on SION in the past 90 days. The average target is $6.00, with a high of $6.00 and a low of $6.00, compared with the last close of $3.07.
Low $6.00Avg $6.00High $6.00
Blue marker: last close $3.07
Highest target$6.00
Average target$6.00
Lowest target$6.00
Latest rating changes
WedbushTarget raised
Sep 15Hold$5 → $6
WedbushDowngrade
Aug 11Hold$53 → $5
GuggenheimMaintained
Aug 7Buy$60
Freedom BrokerDowngrade
May 20Hold$38
StifelMaintained
May 18Buy$55
Date
Firm
Action
Rating
Price target
Sep 15
Wedbush
Target raised
Hold
$5 → $6
Aug 11
Wedbush
Downgrade
Hold
$53 → $5
Aug 7
Guggenheim
Maintained
Buy
$60
May 20
Freedom Broker
Downgrade
Hold
$38
May 18
Stifel
Maintained
Buy
$55
Loading…
Technical Analysis
SION · as of the Nov 17 close · updated after every close
Downtrend, oversold
The stock is 18% below its 20 day and 55% below its 50 day average. It is 806% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 29), oversold. The nearest support is the 52 week low at $3.00, and the nearest resistance the Pivot R1 at $3.15.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 11.3%/day
Key levels
$54.9752 week high+1690.6%
$27.82200 day average+806.2%
$16.92100 day average+451.1%
$4.7550 day average+54.7%
$3.85Swing high (Nov 11)+25.4%
$3.6220 day average+17.9%
$3.15Pivot R1+2.6%
$3.07Pivot+0.0%
$3.07Last close
$3.0052 week low−2.3%
$3.00Pivot S1−2.3%
Indicators
RSI (14)
28.78
Oversold below 30
Oversold
MACD
-0.55
Above its signal line
Bullish
Stochastic
7.1
Near the bottom of its range
Oversold
ADX (14)
38.9
Trending down
Williams %R
-93.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-174.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−15.9%
Change over 10 sessions
Bearish
ATR (14)
$0.35
Typical daily range, 11.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling, oversold
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchOversold
VolatilityNormal, 125.8%/day
Key levels
$54.9752 week high+1690.6%
$27.82200 day average+806.2%
$16.92100 day average+451.1%
$4.7550 day average+54.7%
$3.85Swing high (Nov 11)+25.4%
$3.6220 day average+17.9%
$3.15Pivot R1+2.6%
$3.07Pivot+0.0%
$3.07Last close
$3.0052 week low−2.3%
$3.00Pivot S1−2.3%
Indicators
RSI (14)
28.17
Oversold below 30
Oversold
MACD
-8.78
Below its signal line
Bearish
Stochastic
1.3
Near the bottom of its range
Oversold
ADX (14)
30.5
Trending down
Williams %R
-98.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-52.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−60.9%
Change over 10 sessions
Bearish
ATR (14)
$3.86
Typical daily range, 125.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100–
MA 200–
What happened before, for SION
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how SION did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Whale Options Flow
90D
No whale options trades in SION in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SION is in one of them and how their past SION trades turned out.
Sionna Therapeutics is a drug developer based in Waltham, Massachusetts. It is developing medicines for people with cystic fibrosis, an inherited disease that causes thick mucus to build up in the lungs, pancreas and other organs. Its candidates are designed to stabilize a part of the CFTR protein called NBD1, which is affected by the most common cystic fibrosis mutation. The company is still testing these candidates in clinical trials.